The article Origin Signs Letter of Intent to Acquire Safe Supply Streaming was originally published on Microdose. “We have a public health emergency...
This week Auntie offers thoughts on how to talk with a friend you are concerned about who likes to do fentanyl, broaching the topic of drug...
Most psychedelics clinical trials have some degree of failure in that there are people in the trial who simply can’t tolerate psychedelics as a therapeutic...
The company has raised $39 million to optimize existing substances, which they say will make them safer and more effective. The post Gilgamesh Tweaks Known...
The article News You Might Have Missed: Jan 30th, 2023 was originally published on Microdose. Welcome to the News You Might Have Missed, a weekly roundup...
Final price per share still to be determined. The post Irwin Naturals Signs LOI to Acquire Braxia Scientific appeared first on Green Market Report.
Cybin (NEO: CYBN | NYSE American: CYBN), a biopharmaceutical company focused on progressing Psychedelics to Therapeutics(TM), has scheduled a virtual R&D...
Source: Streetwise Reports 01/25/2023 Streetwise Reports sat down with Øyvind Schanke, the chief investment officer of TD Veen and the former...
Traditional tactics aren't always the most effective ways to raise capital. The post Psychedelics Industry Goal: Find Capital ASAP appeared first on Green...
The article Small Pharma DMT Depression Trial: 57% of Patients Enter Remission was originally published on Microdose. Today, psychedelic medicine company...